Thymalfasin is a synthetic thymosin alpha-1 analogue categorized as an immunomodulating agent used in the treatment of chronic hepatitis B, autoimmune disorders, and various cancers to enhance immune system… Read more













Thymalfasin is a synthetic thymosin alpha-1 analogue categorized as an immunomodulating agent used in the treatment of chronic hepatitis B, autoimmune disorders, and various cancers to enhance immune system function. Analytical laboratories require highly specific reference standards, including impurities and metabolites, to conduct rigorous impurity profiling and ensure the stability and safety of this peptide drug. These high-quality reference materials, along with stable isotope labelled compounds, are critical for the development and validation of analytical methods such as HPLC and mass spectrometry. By utilizing these precise standards, researchers and quality control professionals can accurately identify and quantify related substances, degradation products, and synthesis by-products in complex formulations. Supporting pharmaceutical research and development, these tools facilitate compliance with regulatory quality control requirements for Thymalfasin peptide synthesis and drug product characterization.